FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (KVK-Tech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for methylphenidate hydrochloride extended-release from KVK-Tech, Inc., authorizing changes to the approved generic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE)